Trials / Completed
CompletedNCT01801605
Repetitive Transcranial Magnetic Stimulation in Irritable Bowel Syndrome
Does Repetitive Transcranial Magnetic Stimulation (rTMS) Reduce Rectal Hypersensitivity in Patients With IBS ?
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) on rectal hypersensitivity in patients with irritable bowel syndrome (IBS) in a prospective, randomized, double-blind study.
Detailed description
IBS patients frequently demonstrate a rectal hypersensitivity which could participate to the abdominal pain. rTMS is an effective treatment of neurogenic chronic pain. The aim of the study is to evaluate the efficacy of rTMS on rectal hypersensitivity in patients with IBS in a prospective, randomized, double-blind study. Patients and method: 20 patients with rectal hypersensitivity secondary to IBS will have one active session of rTMS located on the cortical area of the abdominal muscles during 5 consecutive days and one session of simulated rTMS during 5 over consecutive days corresponding to the placebo session. The order of the two session will be randomized. The efficacy of rTMS will be assessed by a rectal barostat to determine the pain or discomfort threshold and by a RIII reflex. The barostat and RIII reflex will be performed at the beginning and at the end of each session. The investigators hope to demonstrate an improvement of the rectal hypersensitivity during the active stimulations compared to the placebo one.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | rTMS | Active session with stimulation and placebo session with fictive stimulation |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2013-03-01
- Last updated
- 2013-03-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01801605. Inclusion in this directory is not an endorsement.